跳至主要内容
临床试验/ACTRN12621000895886
ACTRN12621000895886招募中未知

Evaluation for cirrhotic cardiomyopathy: A prospective study of global cardiac function in decompensated cirrhosis and its clinical significance

Flinders Medical Centre0 个研究点目标入组 80 人开始时间: 2021年7月8日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1.Consecutive consenting cirrhotic patients with ascites and or past history of ascites on diuretics including
  • a)those requiring abdominal paracentesis,
  • b)hydrothorax requiring thoracentesis,
  • c)planned for TIPS.
  • 2. Consecutive cirrhotic patients undergoing LT assessment with or without ascites.

排除标准

  • 1.ongoing sepsis on inotropes;
  • 2.ongoing grade 2–4 hepatic encephalopathy;
  • 3.known coronary artery disease;
  • 4.other known cardiac diagnoses such as valvular heart disease, dilated, hypertrophic and restrictive cardiomyopathy
  • 5. Uncontrolled systemic hypertension
  • 5. Contraindications to dobutamine, including:
  • oPrevious sensitivity to dobutamine
  • oPrevious documented Ventricular Tachycardia or Ventricular Fibrillation

研究者

相似试验